We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

52 hedge funds and large institutions have $596M invested in Sage Therapeutics in 2014 Q3 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRV
Third Rock Ventures
Massachusetts
+$338M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$112M
3
O
OrbiMed
New York
+$15.6M
4
DM
Deerfield Management
New York
+$13.1M
5
RIM
RS Investment Management
California
+$8.38M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$778K +$717K +24,729 New
LCM
27
Landscape Capital Management
New Jersey
$697K +$641K +22,116 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$594K +$546K +18,850 New
AMCA
29
Arthur M. Cohen & Associates
Illinois
$589K +$240K +8,281 New
BG
30
BlackRock Group
United Kingdom
$576K +$529K +18,262 New
Deutsche Bank
31
Deutsche Bank
Germany
$560K +$516K +17,801 New
BIM
32
BlackRock Investment Management
Delaware
$550K +$506K +17,460 New
Northern Trust
33
Northern Trust
Illinois
$439K +$403K +13,911 New
TCIM
34
TIAA CREF Investment Management
New York
$387K +$356K +12,297 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$334K +$307K +10,600 New
CAM
36
Cormorant Asset Management
Massachusetts
$315K +$290K +10,000 New
HHC
37
Hutchin Hill Capital
New York
$315K +$290K +10,000 New
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$261K +$240K +8,277 New
FSA
39
Franklin Street Advisors
North Carolina
$241K +$222K +7,650 New
CSS
40
Cubist Systematic Strategies
Connecticut
$217K +$200K +6,895 New
BlackRock
41
BlackRock
New York
$217K +$200K +6,900 New
TA
42
Teachers Advisors
New York
$169K +$155K +5,360 New
NFA
43
Nationwide Fund Advisors
Ohio
$164K +$150K +5,191 New
TCM
44
Tekla Capital Management
Massachusetts
$158K +$145K +5,000 New
SO
45
STRS Ohio
Ohio
$63K +$58K +2,000 New
Morgan Stanley
46
Morgan Stanley
New York
$58K +$53.5K +1,845 New
MAA
47
Managed Account Advisors
New Jersey
$19K +$17.2K +595 New
BJ
48
BlackRock Japan
Japan
$13K +$11.6K +402 New
TRCT
49
Tower Research Capital (TRC)
New York
$8K +$7.3K +252 New
Citigroup
50
Citigroup
New York
$6K +$5.82K +201 New
1
2
3

SAGE Hedge Fund Activity: Q3 2014 in Review

52 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2014, worth a combined $596M.

Buyers outnumbered sellers: 52 funds opened new SAGE positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Third Rock Ventures, opening a new position worth an estimated $338M.

  • 52 institutional investors held Sage Therapeutics (SAGE) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $596M of Sage Therapeutics stock for Q3 2014.
  • 52 funds opened new Sage Therapeutics positions in Q3 2014 and 0 closed out, a net change of +52 holders.
  • The largest Sage Therapeutics buyer in Q3 2014 was Third Rock Ventures, an estimated $338M added.

Based on aggregated 13F filings for Q3 2014.